Giuseppe
Emeritus
Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria (Euro Surveill., extract, edited)
[Source: Eurosurveillance, full text: <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719">Eurosurveillance - View Article</cite>. Extract, edited.]
Eurosurveillance, Volume 15, Issue 46, 18 November 2010
Editorials
Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria
ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme 1,2
1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
2. Members of the programme are listed at the end of the editorial
Citation style for this article: ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme. Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria . Euro Surveill. 2010;15(46)
ii=19719. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719
Date of submission:...
A year ago in November 2009, a study in this journal highlighted the emergence of infections with totally or almost totally resistant bacteria in European intensive care units [1]. Most of them were Gram-negative bacilli that showed resistance to a class of antibiotics considered last-line therapy: the carbapenems. Already in 2008, Souli et al. had reviewed the emergence of extensively drug-resistant (XDR) bacteria in Europe [2] and pointed out the high proportion of isolates that were resistant to carbapenems, through production of a carbapenemase enzyme. Indeed, an increasing number of reports on carbapenemases and infections with carbapenemase-producing bacteria have been published in recent years indicating the rising importance of these bacteria. A PubMed search with the keyword ?carbapenemase? and excluding review articles, yielded 35 articles for the year 2007, 48 articles for 2008, 80 articles for 2009 and 109 articles for 2010 (as of 14 November).
(...)
-
------<cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719"></cite>
[Source: Eurosurveillance, full text: <cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719">Eurosurveillance - View Article</cite>. Extract, edited.]
Eurosurveillance, Volume 15, Issue 46, 18 November 2010
Editorials
Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria
ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme 1,2
1. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
2. Members of the programme are listed at the end of the editorial
Citation style for this article: ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme. Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria . Euro Surveill. 2010;15(46)
ii=19719. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719Date of submission:...
A year ago in November 2009, a study in this journal highlighted the emergence of infections with totally or almost totally resistant bacteria in European intensive care units [1]. Most of them were Gram-negative bacilli that showed resistance to a class of antibiotics considered last-line therapy: the carbapenems. Already in 2008, Souli et al. had reviewed the emergence of extensively drug-resistant (XDR) bacteria in Europe [2] and pointed out the high proportion of isolates that were resistant to carbapenems, through production of a carbapenemase enzyme. Indeed, an increasing number of reports on carbapenemases and infections with carbapenemase-producing bacteria have been published in recent years indicating the rising importance of these bacteria. A PubMed search with the keyword ?carbapenemase? and excluding review articles, yielded 35 articles for the year 2007, 48 articles for 2008, 80 articles for 2009 and 109 articles for 2010 (as of 14 November).
(...)
-
------<cite cite="http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19719"></cite>